跳至主要内容
临床试验/NCT02274636
NCT02274636Unknown不适用

Study of a Dietary Supplement for Reflux During Sleep

Oral Care Research Associates, Seattle0 个研究点目标入组 50 人开始时间: 2014年10月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
50
主要终点
Reduction in symptoms associated with GERD

研究概览

简要总结

This research study is a randomized, controlled study developed to test how well a dry mouth product that contains xylitol affects some of the symptoms of gastroesophageal reflux disease (GERD. Individuals who experience symptoms of gastro esophageal reflux disease (GERD) and who are accepted into the study will be asked to report on the frequency and severity of several symptoms specific to the condition that occur during sleep. The study is composed of two phases:

Phase one involves collection of baseline information for two weeks. Phase two is the intervention phase of the study. In this phase of the study, each subject will be randomly assigned (like flipping a coin) to use either "the product" of interest or a different dry mouth product for two weeks.

详细描述

The study is composed of two phases:

Phase one involves collection of baseline information for two weeks. Phase two is the intervention phase of the study. In this phase of the study, each subject will be randomly assigned (like flipping a coin) to use either "the product" of interest or a different dry mouth product for two weeks.

Phase 1

This first phase will involve having you report to the research coordinator through email the presence or absence of several symptoms associated with GERD that can occur during sleep. Phase 1 will occur over 14 days (and nights). You will also be asked to rate the relative severity of some of the symptoms. The information collected during this initial phase of the study will then be used to establish baseline values for the symptoms of interest and determine your eligibility for the intervention phase (phase 2) of the study.

Phase 2

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Supportive Care
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • A medical diagnosis of GERD
  • Awakening with a taste of refluxed stomach acid in the mouth
  • Heartburn during sleep
  • Voice hoarseness upon awakening
  • Antacid use at night
  • Dry mouth at bedtime or during the night
  • Experience difficulty chewing, swallowing, and speaking because of dry mouth

排除标准

  • Prior history of any of these conditions:
  • coronary artery disease
  • gallbladder disease
  • gastric or esophageal cancer
  • peptic ulcer disease
  • esophagitis, whether eosinophilic, infectious, or pill based
  • esophageal motility disorders
  • A history of thoracic, esophageal, or gastric surgery
  • No medical examination in the prior year

结局指标

主要结局

Reduction in symptoms associated with GERD

时间窗: two weeks

Email questionnaire containing 9 questions of interest

次要结局

未报告次要终点

研究者

发起方
Oral Care Research Associates, Seattle
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jeff Burgess DDS MSD

Research Coordinator

Oral Care Research Associates, Seattle

相似试验